Why doesn't our messaging move buyers?

Messaging stops moving buyers when the homepage explains the product clearly and never makes the case for change. We scored 302 healthcare software homepages this month on 19 signals. The companies were good at saying what the product does and close to silent on why anyone should act, what it costs to keep doing nothing, and what the buyer would use instead. That gap is the whole problem, and it's fixable without touching the product story you already like.

If your demos go well and your pipeline still stalls at "interesting, let's revisit next year," you're almost certainly living in that gap. Here's the measurement, then the fix.

What's actually wrong with most B2B messaging?

We ran the Brand Signal Score across 302 health tech companies in August 2026 and published the results as the Health Tech Messaging Index. Nineteen signals, two points each, 38 possible. The median score was 19 out of 38. Exactly half.

The median matters less than the shape underneath it: which signals carried the score, and which ones collapsed.

Read that table twice. Health tech companies score near the top of the rubric on describing the solution and near the floor on everything about the problem. Solution Clarity averages 1.56. Problem Leadership averages 0.59. The same page that explains a workflow engine in one crisp sentence never says what the clinician's Tuesday looks like without it.

Alternatives Acknowledged is the one that should stop you. It averaged 0.10 out of 2, and 275 of the 302 companies scored a flat zero. Nine out of ten health tech homepages never acknowledge that the buyer has another option, including the option they're using right now.

Why does explaining the product stop working?

Because in health tech the competitor is usually the status quo, which is entrenched, paid for, and defensible.

Your buyer owns an EHR with a module that half-covers what you do. Staff are already absorbing the manual work. Somewhere there's a workaround somebody built in 2019 that everyone complains about and nobody replaces. When your homepage skips straight to what your product does, you're arguing against a competitor the page never names, and the buyer finishes the page thinking "nice, we sort of do this already."

This is Solution-Centric Marketing in its purest form, and health tech has a specific reason for falling into it. The teams are technical and clinically credible. They know the product deeply. Explaining it is the thing they're best at, so the page becomes the thing they're best at. The buyer's problem gets one sentence at the top because everyone in the building already understands the problem and forgets the visitor doesn't.

The result is the pattern we diagnose constantly: weaker competitors win deals because they sound clearer about why change matters, not because they built more.

How do we name the alternative without attacking anyone?

Name the behavior, not the vendor. This is about showing a buyer you understand the actual choice in front of them.

For most health tech companies the honest alternative list is short: keep doing it manually, use the module already bundled in the system they own, hire more people, or wait another budget cycle. Write those down. Then say plainly what each one costs, in the units the buyer measures. Hours per clinician per week. Denials per month. Days in accounts receivable. Nurse turnover. Time to first appointment.

A page that says "most health systems handle this with two FTEs and a spreadsheet, which works until volume doubles" has done more selling than three paragraphs of feature copy. It shows you've been in the room. It also gives your clinical champion the sentence they need when they carry your case to a committee you'll never meet.

That's the Cost of Inaction signal, and at 0.46 out of 2 it's the cheapest point on the board for most health tech companies to pick up this quarter.

What about the clinical and economic buyers?

Both of them need the problem framed before either one cares about the product, and they need different proof afterward. We wrote the full method for that in positioning for clinical and economic buyers at once: one narrative, two proof layers, a shared villain both buyers already resent.

The index data explains why so many teams get the sequencing backwards. When Problem Leadership scores 0.59, there's no shared villain on the page for either buyer to recognize. Each one lands on a features grid and has to translate it into their own stakes without help. The clinician wonders about workflow disruption. The CFO wonders about a number nobody supplied. Neither gets what they came for, and the committee stalls without ever disagreeing about anything.

Does any of this affect whether AI recommends us?

It does, and we measured that too. In the same run we asked AI engines to recommend companies in each of these 302 companies' own categories. The engines named the company in half the cases. For 152 of 302, the company never came up in its own category at all.

There's a mechanical reason. AI engines answer buyer questions by retrieving text they can attribute and repeat. Buyers ask problem-shaped questions: how do we cut prior-auth turnaround, why are our denials climbing, what do hospitals use for this. A page written entirely in solution vocabulary has nothing matching the question. It reads as a product description of something the engine can't place in a situation.

This is the same failure showing up in a second channel. Buyers now shortlist vendors without visiting websites, which means the page now fails twice over: once for the visitor, and once for the machine that decides whether a visitor ever arrives.

“Nine out of ten homepages never name what the buyer would do instead, which is why the status quo keeps winning deals nobody realizes it was in.”

... Greg Rosner

How do we tell if our homepage has this problem?

Three checks, and you can run all of them this afternoon.

• Count the paragraphs above your first product screenshot. If the buyer's problem gets fewer lines than your feature set, you've found it.
• Search your own homepage for the words your buyer would use for the status quo: manually, spreadsheet, workaround, in-house, the module they already own. If none of them appear, you're at zero on Alternatives Acknowledged like 91% of the field.
• Run the Three Questions Test on the top of your page: why change, why change now, why change with you. Most health tech homepages answer the third question well and the first two not at all.

If you want the scored version rather than the self-assessment, the Brand Signal Score runs the same 19 signals on your homepage that we ran on those 302 companies, and tells you where AI engines currently place you in your category.

What should we fix first?

Start with the top of the homepage, and change the order rather than the content. Most health tech companies already have the problem language somewhere on the site, buried in a case study or a blog post written by a clinician. Move it up. Lead with the situation the buyer is in, name what they're doing about it today and what that costs, then bring in the product as the change.

The deeper fix is that this keeps happening because nothing in the company writes down what's true about the buyer's problem in a form the whole team can use. Every new hire, every rewrite, every AI-drafted page reverts to solution vocabulary because solution vocabulary is what's documented. That's the job of the Magnetic Messaging Framework: extract the truth about who you serve, what's failing them, and what changes, then write it down so the homepage, the deck, and the AI tools your team uses all pull from the same source.

Health tech is the vertical where this pays back fastest, because the buying committee is large, the status quo is strong, and the technical story is usually already excellent. The product story you already like stays exactly as it is. What gets added is the case for change that was never on the page.